Levamisole Induced Agranulocytosis in a Child with Steroid Dependent Nephrotic Syndrome: A Case Report.
agranulocytosis; immunomodulator; levamisole; steroid-dependent nephrotic syndrome.
Journal
JNMA; journal of the Nepal Medical Association
ISSN: 1815-672X
Titre abrégé: JNMA J Nepal Med Assoc
Pays: Nepal
ID NLM: 0045233
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
received:
30
07
2024
medline:
6
10
2024
pubmed:
6
10
2024
entrez:
6
10
2024
Statut:
epublish
Résumé
Levamisole has been used as an effective immunomodulator. Levamisole has been used for nephrotic syndrome due to its immunostimulant, immunomodulating, and steroid-sparing effects. Common adverse effects of levamisole are gastrointestinal symptoms (nausea, abdominal cramps), and pyrexia. However, agranulocytosis or pancytopenia is also a rare but life-threatening complication of levamisole. This is a case report of a 5-year-old girl who had steroid-dependent nephrotic syndrome for which she was started on levamisole as per her weight, following which she had falling total leukocyte count levels on every visit. Thus, this case report emphasizes identifying this rare side effect and its management.
Substances chimiques
Levamisole
2880D3468G
Adjuvants, Immunologic
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM